RG-4733 Completed Phase 2 Trials for Clear Cell Renal Cell Carcinoma / Stage IV Renal Cell Cancer / Renal Cell Carcinoma Recurrent Treatment

Indications	Status	Purpose	Phase
DBCOND0029155 (Clear Cell Renal Cell Carcinoma) DBCOND0028779 (Stage IV Renal Cell Cancer) DBCOND0078870 (Renal Cell Carcinoma Recurrent)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01141569	A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy	RG-4733 (DB11870)